1. Home
  2. NVCR vs VSCO Comparison

NVCR vs VSCO Comparison

Compare NVCR & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • VSCO
  • Stock Information
  • Founded
  • NVCR 2000
  • VSCO 1977
  • Country
  • NVCR Switzerland
  • VSCO United States
  • Employees
  • NVCR N/A
  • VSCO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • VSCO Clothing/Shoe/Accessory Stores
  • Sector
  • NVCR Health Care
  • VSCO Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • VSCO Nasdaq
  • Market Cap
  • NVCR 2.3B
  • VSCO 2.2B
  • IPO Year
  • NVCR 2015
  • VSCO N/A
  • Fundamental
  • Price
  • NVCR $22.09
  • VSCO $27.96
  • Analyst Decision
  • NVCR Buy
  • VSCO Hold
  • Analyst Count
  • NVCR 5
  • VSCO 12
  • Target Price
  • NVCR $33.40
  • VSCO $40.33
  • AVG Volume (30 Days)
  • NVCR 741.8K
  • VSCO 2.1M
  • Earning Date
  • NVCR 02-27-2025
  • VSCO 03-05-2025
  • Dividend Yield
  • NVCR N/A
  • VSCO N/A
  • EPS Growth
  • NVCR N/A
  • VSCO 54.91
  • EPS
  • NVCR N/A
  • VSCO 1.95
  • Revenue
  • NVCR $577,738,000.00
  • VSCO $6,207,000,000.00
  • Revenue This Year
  • NVCR $19.97
  • VSCO $2.99
  • Revenue Next Year
  • NVCR $2.83
  • VSCO $1.74
  • P/E Ratio
  • NVCR N/A
  • VSCO $14.32
  • Revenue Growth
  • NVCR 14.63
  • VSCO 1.42
  • 52 Week Low
  • NVCR $11.70
  • VSCO $15.12
  • 52 Week High
  • NVCR $34.13
  • VSCO $48.73
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 36.77
  • VSCO 20.67
  • Support Level
  • NVCR $21.38
  • VSCO $31.65
  • Resistance Level
  • NVCR $22.95
  • VSCO $33.22
  • Average True Range (ATR)
  • NVCR 0.86
  • VSCO 1.46
  • MACD
  • NVCR 0.01
  • VSCO -0.40
  • Stochastic Oscillator
  • NVCR 34.25
  • VSCO 3.39

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime. The Company operates as a single segment designed to serve customers worldwide seamlessly through stores and online channels.

Share on Social Networks: